Tom Carper - Delaware Business Times

Bioscience and pharmaceutical, Economic Development, Education, Government, New Castle County, News

NIIMBL gets $15M in federal earmarks for expansion

Jacob Owens January 9, 2023

The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) got $15 million in federal earmarks for its expansion.

0 Comment 728 Views

Shailen Bhatt DelDOT FHWA

Government, News, Statewide, Transportation

Former DelDOT chief Bhatt confirmed to top highway role

Jacob Owens December 22, 2022

WASHINGTON – Shailen Bhatt, the former Delaware Department of Transportation secretary in the Markell administration, was confirmed earlier this month to lead the Federal Highway Administration (FHWA). The Dec. 8 […]

0 Comment 170 Views

Economic Development, Government, Health Care, Insider Only, Manufacturing & Distribution, New Castle County, News, Technology & IT

🔒 🔒 Hologic plans growth despite chip shortage

Jacob Owens December 9, 2022

GLASGOW – The medical technology company Hologic has big plans to build a new $24 million research and development, and manufacturing center at its Glasgow Business Community campus, but it […]

0 Comment 273 Views

Chemicals, Economic Development, Energy, Manufacturing & Distribution, New Castle County, News

Bloom Energy opens first electrolyzer production line

Jacob Owens November 1, 2022

NEWARK – As evidence of Bloom Energy’s confidence in hydrogen as a renewable fuel source of the future, it opened its first dedicated production line for electrolyzers in its Newark […]

1 Comment 847 Views

Editorial, Insider Only, News

🔒 🔒 EDITORIAL: Will Biden’s summer swoon lead to historic wins?

Jacob Owens September 23, 2022

It may feel farther away, but this year’s midterm elections are now less than 60 days away. Midterms are always the less glamorous turn to the polls compared to presidential […]

0 Comment 314 Views

Premier Digital Partners

© 2023 Delaware Business Times

[caption id="attachment_225683" align="aligncenter" width="1200"] NIIMBL National Institute for Innovation in Manufacturing Biopharmaceuticals Kelvin Lee

NIIMBL National Institute for Innovation in Manufacturing Biopharmaceuticals Kelvin Lee

(L-R) NIIMBL Director Kelvin Lee talks with Sen. Tom Carper, NIST Director Laurie Locascio, Sen. Chris Coons, UD President Dennis Assanis and his wife, Eleni, during a September tour of the Ammon Pinizzotto Biopharmaceutical Innovation Center. The federal delegation recently secured $15 million for NIIMBL. | DBT PHOTO BY JACOB OWENS[/caption] NEWARK – The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) received $15 million in total federal earmarks last month to support its planned expansion on the University of Delaware’s STAR Campus. Delaware’s federal delegation, including Sens. Tom Carper and Chris Coons, and Rep. Lisa Blunt Rochester, lobbied support for the congressionally directed spending in the latest omnibus appropriations bill to support the public-private entity that advances the nation’s biopharmaceutical manufacturing capabilities. NIIMBL already operates research labs and offices out of the Ammon Pinizzotto Biopharmaceutical Innovation Center on the STAR Campus, but it will next build the SABRE Center, which is an acronym for Securing American Bio-Manufacturing Research and Education. It will be located on an empty plot of land just to the north of the Pinizzotto labs, officials announced in September, and be a so-called current Good Manufacturing Practices (cGMP) facility that would support biopharmaceutical innovation for clinical research in preparation for future public health emergencies. University officials have said the SABRE Center project would be a space for research in the manufacturing sector as well as workforce training and development around vaccines, therapeutics and biopharmaceuticals – a burgeoning industry in northern Delaware. While essentially a R&D and training facility, it would also be a fully functioning manufacturing plant that could pitch in to help scale the production of vaccines or other drugs for clinical trials or in response to outbreaks. The federal delegation secured $5 million total in the last appropriations bill to begin design on the SABRE Center, with $3 million more supporting equipment acquisition. In the latest funding, $10 million is allocated to construct the facility with $5 million more for equipment. “With this funding, we’re one step closer to seeing NIIMBL’s vision at the University of Delaware realized. That means major investments in the research and development of life-saving medicines, the creation of good-paying jobs, the training to perform these jobs, and the economic vitality of our state,” Blunt Rochester said in a statement. NIIMBL Director Kelvin Lee said the SABRE Center was still in the design phase and a construction timeline was not yet available, but he thanked the elected officials for advancing the financial support. “We are so grateful for the very hard work that our entire federal delegation does to support our work and vision. These Congressionally-directed projects and initiatives create important opportunities for innovation and job growth in ways that will support NIIMBL's mission as well as economic development in the state,” he said. Coons, who has championed NIIMBL through the federal Manufacturing USA network that he helped design, said the SABRE Center would be important to advancing bioscience in the country. “NIIMBL, with a GMP testbed facility, would be a real hub for both demonstrating new cutting-edge manufacturing processes and training Delawareans in how to use them. Then my hope is that it would generate several new spinoff companies or attract new companies from around the world,” he told Delaware Business Times, noting it has already helped land one major prospect in WuXi STA Pharmaceutical. “The complex in Middletown could ultimately be thousands of jobs, and across the NIIMBL network nationally workforce development is a key goal.” In another important distinction, Coons secured an amendment in the annual National Defense Authorization Act that would allow NIIMBL’s federal sponsor agency, the National Institute of Standards and Technology (NIST), to directly support Manufacturing USA projects without the need for congressional earmarks. “That means NIST can now directly support the construction of the good manufacturing practices facility at NIIMBL,” Coons explained.